Meeting
2024 ASCO Genitourinary Cancers Symposium
Racial and ethnic differences in the receipt of metabolic syndrome risk factor screening and treatment among individuals with prostate cancer treated with androgen deprivation therapy.
Authors
Yazan K. Barqawi
University of New Mexico College of Pharmacy, Albuquerque, NM
Yazan K. Barqawi , Matthew E Borrego , Melissa H Roberts , Todd Thompson , Neda Hashemi-Sadraei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 29)
DOI
10.1200/JCO.2024.42.4_suppl.29
Abstract #
29
Poster Bd #
A8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Exercise to enhance cardiovascular health among Black patients with prostate cancer with androgen deprivation therapy: The POWER trial.
First Author: Dong-Woo Kang
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio).
First Author: Andrew Warren Hahn
Poster
2023 ASCO Genitourinary Cancers Symposium
Management disparities in metastatic castrate-sensitive prostate cancer (mCSPC).
First Author: Nataliya Mar
Poster
2023 ASCO Genitourinary Cancers Symposium
Health disparities in metastatic hormone-sensitive prostate cancer (mHSPC) presentations and outcomes among Hispanic Americans (HA) versus non-Hispanic Whites (NHW).
First Author: Aaron Bertolo